MentionFox
Home › funding signals › Longeveron Inc.
Form D · on the record

Longeveron Inc. — $15.89M Form D filing, March 2026

Longeveron Inc. filed a Form D with the Securities and Exchange Commission on 2026-03-25.

Longeveron Inc. filed a Form D notice of an exempt securities offering with the SEC on March 25, 2026. The filing reports $15.89M sold. Its industry group is Biotechnology. It names Stephen Willard (Executive Officer), Joshua Hare (Executive Officer, Director), Lisa Locklear (Executive Officer) (SEC Form D, March 25, 2026).

125 companies raised this week.

Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.

Andersen Aggregator LLC$1.9BBusiness services
AT Umbrella LLC$1.9BBusiness services
Legora, Inc.$221MAI and software
MD INVESTMENT LLC$169MBusiness services
Serval Inc.$149MAI and software
Check one company free

2 more Biotechnology raises in Florida, March 2026 ↓

Is this your company?

Key facts

Run the free check on Longeveron Inc. →

Sell to companies like Longeveron Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

Longeveron Inc.

New Form D on file · 2026-03-25 · the record

$15.89M
raise on the record
D
filing
7
investors in
FLORIDA
based
Open the record →

What the record says

FilingForm D
Filed2026-03-25
Industry groupBiotechnology
Entity typeCorporation
Incorporated inDELAWARE
BasedMIAMI, FLORIDA
CIK1721484
Accession0001721484-26-000001

Pitching, partnering or investing alongside them? See who really runs and owns Longeveron Inc.

Free to see. No signup.

Keep reading

More on the people and the money behind Longeveron Inc., from the filings we hold.

Raised through the same sales agent

H.C. Wainwright & Co., LLC received sales compensation on this raise and on 30 other raises we hold, nearest in date first:

More raises like this

Biotechnology raises by companies based in Florida, filed in March 2026, largest first.

What do you want to do with Longeveron Inc.?

Get the full cited report on Longeveron Inc.

What the filing shows about Longeveron Inc.

  • 7 investors had already put money in when it filed.
  • The filing names 10 people as officers, directors or promoters.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News

A Full Report on Longeveron Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

See a sample report

Who the filing names, and in what role

The filing gives Longeveron Inc.'s address as 1951 Nw 7TH Avenue, Suite 520, Miami, FL 33136.

What the filing says

  • Offered: $33,515,000. Sold: $15,890,000. Left to sell: $17,625,000. (filing)
  • Investors: 7 had already invested. (filing)
  • Date of first sale: March 11, 2026. (filing)
  • Types of securities: Equity; Options, warrants or other rights to acquire another security; Securities to be acquired on exercise of an option, warrant or other right; Other: An interest in 50% of proceeds received (after deducting fees) from the potential future sale of a Rare Pediatric Disease Priority Review Voucher, to the extent received from the U.S. FDA in connection with the Company's laromestrocel program for HLHS.. (filing)
  • Item 16: the filing reports that none of the proceeds goes to executive officers, directors or promoters. (filing)
  • On the amounts offered and sold: the filing adds “Total offering amount: purchase price of shares of Class A common stock, Series A Preferred Stock, an interest in future proceeds from a potential future PRV sale, proceeds due to Company assuming cash exercise of all warrants issued to placement agent” (filing)
  • On sales commissions and finders' fees: the filing adds “At initial closing, placement agent received $1,112,300.01 & warrants to purchase up to 2,019,231 shares of Common Stock exercisable at $0.65 per share, among other items. Contingent upon a second closing, placement agent will receive an identical comp.” (filing)

This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.

Order the Full Report on Longeveron Inc. See pricing

Is Longeveron Inc. a real, registered company?

Longeveron Inc. is a registered filer with the SEC (CIK 1721484) and has filed since 2023-10-24. 6 filings are on record, the latest on 2026-03-25.

A filing shows the company exists and what it reports about itself. It is not an audit or a rating.

Who runs Longeveron Inc.?

Longeveron Inc.'s Form D of 2026-03-25 names Stephen Willard, Joshua Hare, Lisa Locklear and 7 more as its officers, directors or promoters.

How much has Longeveron Inc. raised?

Its new offerings report $15.89M sold across 1 offering, as its own filings state.

Filing history · 6 filings on this registrant
Form D · 2023-10-24Form D · 2024-01-08Form D · 2024-04-25Form D · 2024-06-25Form D · 2024-07-23Form D · 2026-03-25 · $15.89M · this page 2023-10-24 2026-03-25

Each marker is one filing. The larger marker is the filing this page is about.

Biotechnology · by week
This raise, $15.89M, filed week of Mar 23

Trailing twelve months. 771 filings in Biotechnology, totalled by week. The dot is this raise, $15.89M, on the same scale — one filing against the whole group's total, so it sits low by construction.

Want the whole picture on Longeveron Inc.?

What the filing shows about Longeveron Inc.

  • 7 investors had already put money in when it filed.
  • The filing names 10 people as officers, directors or promoters.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News

A Full Report on Longeveron Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Longeveron Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    2 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The full profile

Checking your access…

Is this you?

If you're behind Longeveron Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.

Sourced from the filing index on sec.gov, and from the company's own site, read directly on 2026-09-26 (investors.longeveron.com).

Follow this companyRSS

Tools for this story

Each opens in a new tab, filled in for Longeveron Inc.. With no account yet, you sign up free and land on the result.

On these startup lists

Biotech startups

More on Longeveron Inc.

Share this page

Is this your company?

Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.

Longeveron Inc.: Raised $15.89M, Form D filed 2026-03-25
Share on LinkedIn Share on X Download image

Cite this page

Permanent URL: https://mentionfox.com/funding/longeveron-inc-form-d-26000001
Last updated 2026-10-20
Primary record: SEC filing 1 · SEC filing 2
Longeveron Inc. raised $15.89M — SEC Form D filing, March 2026. MentionFox, 2026-10-20. https://mentionfox.com/funding/longeveron-inc-form-d-26000001